Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods

References

• Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-55. doi:10.1016/S0140-6736(10)60206-1. PMID:20399493
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi:10.1016/S0140-6736(12)61728-0. PMID:23245604
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247(4949 Pt 1):1465-8. doi:10.1126/science.1690918. PMID:1690918
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993;259(5102):1745-9. doi:10.1126/science.8456302. PMID:8456302
   PubMed Web of Science ®Google Scholar
• Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1993;90(9):4156-60. doi:10.1073/pnas.90.9.4156. PMID:8483929
   PubMed Web of Science ®Google Scholar
• Weiner DB. DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine. 2008;26(40):5073-4. doi:10.1016/j.vaccine.2008.07.024. PMID:18652867
   PubMed Web of Science ®Google Scholar
• Niidome T, Huang L. Gene therapy progress and prospects: Nonviral vectors. Gene Ther. 2002;9(24):1647-52. doi:10.1038/sj.gt.3301923. PMID:12457277
   PubMed Web of Science ®Google Scholar
• Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: Prospects for success. Curr Opin Immunol. 2011;23(3):421-9. doi:10.1016/j.coi.2011.03.008. PMID:21530212
   PubMed Web of Science ®Google Scholar
• Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M. Sonoporation: Gene transfer using ultrasound. World J Methodol. 2013;3(4):39-44. doi:10.5662/wjm.v3.i4.39. PMID:25237622
   PubMedGoogle Scholar
• Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84(21):7413-7. doi:10.1073/pnas.84.21.7413. PMID:2823261
   PubMed Web of Science ®Google Scholar
• Aihara H., Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol. 1998;16(9):867-70. doi:10.1038/nbt0998-867. PMID:9743122
   PubMed Web of Science ®Google Scholar
• Johnston SA, Tang DC. Gene gun transfection of animal cells and genetic immunization. Methods Cell Biol. 1994;43(Pt A):353-65. doi:10.1016/S0091-679X(08)60612-3. PMID:7823871
   PubMedGoogle Scholar
• Laddy DJ, Yan J, Khan AS, Andersen H, Cohn A, Greenhouse J, Lewis M, Manischewitz J, King LR, Golding H, et al. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol. 2009;83(9):4624-30. doi:10.1128/JVI.02335-08. PMID:19211745
   PubMed Web of Science ®Google Scholar
• Nyström J, Chen A, Frelin L, Ahlén G, Koh S, Brass A, Peterson DL, Fons M, Milich DR, Hultgren C, et al. Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes. J Infect Dis. 2010;201(12):1867-79. doi:10.1086/652808. PMID:20446851
   PubMed Web of Science ®Google Scholar
• Rosati M, Valentin A, Jalah R, Patel V, von Gegerfelt A, Bergamaschi C, Alicea C, Weiss D, Treece J, Pal R. Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine. 2008;26(40):5223-9. doi:10.1016/j.vaccine.2008.03.090. PMID:18468743
   PubMed Web of Science ®Google Scholar
• Livingston BD, Little SF, Luxembourg A, Ellefsen B, Hannaman D. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine. 2010;28(4):1056-61. doi:10.1016/j.vaccine.2009.10.111. PMID:19896452
   PubMed Web of Science ®Google Scholar
• Bachy M, Boudet F, Bureau M, Girerd-Chambaz Y, Wils P, Scherman D, Meric C. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine. 2001;19(13-14):1688-93. doi:10.1016/S0264-410X(00)00406-0. PMID:11166892
   PubMed Web of Science ®Google Scholar
• Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, Edwards L, Parker RL, Denny L, Giffear M, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: A randomised, double-blind, placebo-controlled phase 2b trial. Lancet. 2015;386(10008):2078-88. doi:10.1016/S0140-6736(15)00239-1. PMID:26386540
   PubMed Web of Science ®Google Scholar
• Kim TJ, Jin HT, Hur SY, Yang HG, Seo YB, Hong SR, Lee CW, Kim S, Woo JW, Park KS, et al. Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients. Nat Commun. 2014;5:5317. doi:10.1038/ncomms6317. PMID:25354725
   PubMed Web of Science ®Google Scholar
• Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC 3rd, Murphy BR. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol. 1994;68(8):5321-5. PMID:8035532
   PubMed Web of Science ®Google Scholar
• Li X, Sambhara S, Li CX, Ewasyshyn M, Parrington M, Caterini J, James O, Cates G, Du RP, Klein M. Protection against respiratory syncytial virus infection by DNA immunization. J Exp Med. 1998;188(4):681-8. doi:10.1084/jem.188.4.681. PMID:9705950
   PubMed Web of Science ®Google Scholar
• Olmsted RA, Elango N, Prince GA, Murphy BR, Johnson PR, Moss B, Chanock RM, Collins PL. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: Comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A. 1986;83(19):7462-6. doi:10.1073/pnas.83.19.7462. PMID:3532115
   PubMed Web of Science ®Google Scholar
• Storch GA. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics. 1998;102(3 Pt 1):648-51. doi:10.1542/peds.102.3.648. PMID:9738192
   PubMed Web of Science ®Google Scholar
• Isaacs D, Bangham CR, McMichael AJ. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet. 1987;2(8562):769-71. doi:10.1016/S0140-6736(87)92502-5. PMID:2888988
   PubMed Web of Science ®Google Scholar
• Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011;162(1–2):80-99. doi:10.1016/j.virusres.2011.09.020. PMID:21963675
   PubMed Web of Science ®Google Scholar
• Openshaw PJ, Clarke SL, Record FM. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol. 1992;4(4):493-500. doi:10.1093/intimm/4.4.493. PMID:1591217
   PubMed Web of Science ®Google Scholar
• Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J Virol. 1998;72(4):2871-80. PMID:9525607
   PubMed Web of Science ®Google Scholar
• Li X, Sambhara S, Li CX, Ettorre L, Switzer I, Cates G, James O, Parrington M, Oomen R, Du RP, et al. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Virology. 2000;269(1):54-65. doi:10.1006/viro.2000.0186. PMID:10725198
   PubMed Web of Science ®Google Scholar
• Niewiesk S, Prince G. Diversifying animal models: The use of hispid cotton rats (Sigmodon hispidus) in infectious diseases. Lab Anim. 2002;36(4):357-72. doi:10.1258/002367702320389026. PMID:12396279
   PubMedGoogle Scholar
• Ternette N, Tippler B, Uberla K, Grunwald T. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine. 2007;25(41):7271-9. doi:10.1016/j.vaccine.2007.07.025. PMID:17825960
   PubMed Web of Science ®Google Scholar
• Hua Y, Jiao YY, Ma Y, Peng XL, Fu YH, Zheng YP, Hong T, He JS. DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice. Immunol Lett. 2016;179:95-101. doi:10.1016/j.imlet.2016.09.011. PMID:27688078
   PubMed Web of Science ®Google Scholar
• Liljeroos L, Krzyzaniak MA, Helenius A, Butcher SJ. Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A. 2013;110(27):11133-8. doi:10.1073/pnas.1309070110. PMID:23776214
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Chen L, Srivatsan S, Zheng A, et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science. 2013;342(6158):592-8. doi:10.1126/science.1243283. PMID:24179220
   PubMed Web of Science ®Google Scholar
• Smith TRF, Schultheis K, Morrow MP, Kraynyak KA, McCoy JR, Yim KC, Muthumani K, Humeau L, Weiner DB, Sardesai NY, et al. Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus. Vaccine. 2017;35(21):2840-47. doi:10.1016/j.vaccine.2017.04.008. PMID:28413132
   PubMed Web of Science ®Google Scholar
• Grunwald T, Tenbusch M, Schulte R, Raue K, Wolf H, Hannaman D, de Swart RL, Uberla K, Stahl-Hennig C. Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates. J Virol. 2014;88(8):3997-4007. doi:10.1128/JVI.02736-13. PMID:24453366
   PubMed Web of Science ®Google Scholar
• Stab V, Nitsche S, Niezold T, Storcksdieck Genannt Bonsmann M, Wiechers A, Tippler B, Hannaman D, Ehrhardt C, Uberla K, Grunwald T, et al. Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus. PLoS One. 2013;8(8):e72217. doi:10.1371/journal.pone.0072217. PMID:23967287
   PubMed Web of Science ®Google Scholar
• Smith TR, Schultheis K, Kiosses WB, Amante DH, Mendoza JM, Stone JC, McCoy JR, Sardesai NY, Broderick KE. DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response. Mol Ther Methods Clin Dev. 2014;1:14054. doi:10.1038/mtm.2014.54. PMID:26052522
   PubMed Web of Science ®Google Scholar
• Schultheis K, Schaefer H, Yung BS, Oh J, Muthumani K, Humeau L, Broderick KE, Smith TR. Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine. 2017;35(1):61-70. doi:10.1016/j.vaccine.2016.11.052. PMID:27894716
   PubMed Web of Science ®Google Scholar
• Bahl K, Senn JJ, Yuzhakov O, Bulychev A, Brito LA, Hassett KJ, Laska ME, Smith M, Almarsson Ö, Thompson J, et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol Ther. 2017;25(6):1316-27. doi:10.1016/j.ymthe.2017.03.035. PMID:28457665
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017;543(7644):248-51. doi:10.1038/nature21428. PMID:28151488
   PubMed Web of Science ®Google Scholar
• DeFrancesco L. The ‘anti-hype’ vaccine. Nat Biotechnol. 2017;35(3):193-197. doi:10.1038/nbt.3812. PMID:28244993
   PubMed Web of Science ®Google Scholar
• Geall AJ, Verma A, Otten GR, Shaw CA, Hekele A, Banerjee K, Cu Y, Beard CW, Brito LA, Krucker T, et al. Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A. 2012;109(36):14604-9. doi:10.1073/pnas.1209367109. PMID:22908294
   PubMed Web of Science ®Google Scholar
• Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25(7):1467-75. doi:10.1016/j.ymthe.2017.03.013. PMID:28412170
   PubMed Web of Science ®Google Scholar